BPG is committed to discovery and dissemination of knowledge
Minireviews
Copyright: ©Author(s) 2026.
World J Clin Pediatr. Sep 9, 2026; 15(3): 119877
Published online Sep 9, 2026. doi: 10.5409/wjcp.v15.i3.119877
Table 3 Clinical-etiological profiles of key pediatric occipital epilepsy syndromes
Feature
Self-limited epilepsy with autonomic seizures
Childhood occipital visual epilepsy
Photosensitive occipital lobe epilepsy
Structural occipital lobe epilepsy
Former namePanayiotopoulos syndromeGastaut-type idiopathic childhood occipital epilepsyIdiopathic photosensitive occipital epilepsySymptomatic occipital lobe epilepsy
Core age at onsetPeak: 3-6 years. Range: 1-14 yearsPeak: Approximately 8 years. Range: 3-16 yearsLate childhood to adolescence (mean age approximately 11 years)Variable, often in early childhood or infancy
Defining semiologyProlonged nocturnal autonomic seizures (emesis, pallor) often evolve into impaired awarenessBrief diurnal visual sensory seizures (elementary hallucinations, ictal blindness)Reflex visual seizures triggered by specific visual stimuli (flicker patterns)Heterogeneous. Visual symptoms, in addition to prominent motor, cognitive, or behavioral features
EEG hallmarkMultifocal spikes with posterior emphasis, marked sleep activation, and shifting fociOccipital paroxysms: Hallmark of fixation-off sensitivityOccipital spikes/polyspikes elicited by intermittent photic stimulationFocal occipital discharges and background slowing were common. ESES pattern may occur
Etiology (ILAE axis)Genetics (developmental)Genetics (developmental)Genetic (strong photoparoxysmal response trait)Structural (e.g., cortical dysplasia, tumors, and stroke)
Neuroimaging (MRI)Normal. This may be deferred in a prototypical presentationNormal. It is mandatory to exclude structural mimicsNormal. It is recommended to exclude a structural basisAbnormal. The defining feature. The causative lesion was identified
Typical courseHighly self-limited. Low total seizure burden; remission within 1-3 yearsFavorable but variable. Responsive to ASMs; remission in 50%-80% by late adolescenceChronic but manageable. Controlled with trigger avoidance and/or ASMsChronic and often drug-resistant infections. Epilepsy surgery evaluation may be required


Write to the Help Desk